Genzyme's Lemtrada™ Approved in Brazil for Treatment of Multiple Sclerosis

Genzyme's Lemtrada™ Approved in Brazil for Treatment of Multiple Sclerosis “Lemtrada is an innovative treatment, with clinical trial data that support its potential to meaningfully address relapse rates and disability in patients with active MS,” said Maria Lucia Brito Ferreira,… Continue Reading